What is AIM Trials?
AIM Trials operates as a clinical research organization based in Plano and Dallas, with a specialized focus on mental health and general medicine trials for both adult and pediatric populations. The organization is dedicated to advancing healthcare by conducting a diverse array of studies, including those targeting conditions such as autism, depression, and irritable bowel syndrome. AIM Trials prioritizes patient safety and comfort, offering participants access to cutting-edge treatments while contributing to the evolution of medical science. Furthermore, the company provides robust research services to sponsors and healthcare providers, ensuring efficient trial oversight and precise data acquisition.
How much funding has AIM Trials raised?
AIM Trials has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for AIM Trials?
The substantial late-stage funding positions AIM Trials for accelerated growth and expanded operational capacity. This strategic capital infusion is expected to fuel further development of their clinical trial infrastructure and potentially broaden their research into new therapeutic areas. The company's focus on mental health and general medicine trials, coupled with its commitment to sponsor services, suggests a trajectory aimed at solidifying its market leadership and driving innovation in clinical research.
See full AIM Trials company page
